Trumpcare ’ s prospects dim, but not too dim to hit stent graft makers
The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers’ stocks.
The Affordable Care Act covers a 1-time screening for abdominal aortic aneurysms in men who smoke or smoked in the past, listing the test as an “essential health benefit.”
The GOP’s healthcare reform proposal would do away with the AAA screening coverage, shifting the cost of the test to patients, which could in turn affect AAA repair procedure volumes. Investors reacted by pushing share prices down yesterday on Wall Street for Lombard Medic...
Source: Mass Device - April 5, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Healthcare Reform Stent Grafts Wall Street Beat C.R. Bard Capitol Hill Endologix Lombard Medical Technologies Source Type: news
Lombard, MicroPort finalize strategic partnership
Lombard Medical Technologies (NSDQ:EVAR) said today it finalized a strategic partnership deal with MicroPort Scientific.
Through the partnership, MicroPort will manufacture certain components for Lombard’s Aorfix and Altura product lines at its Shanghai facilities, slated to begin in the 2nd half of this year.
“This strategic partnership begins to establish the foundation for improved gross margins for Lombard by significantly reducing the manufacturing costs of both Aorfix and Altura devices which, in turn, will allow Lombard to be competitive in all of our markets. Moreover, given MicroPort’s exceptional m...
Source: Mass Device - April 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Vascular Lombard Medical Technologies MicroPort Scientific Source Type: news
MicroPort, undaunted by price caps, enters India ’ s stent market
MicroPort has entered the Indian market only days after the country’s National Pharmaceutical Pricing Authority imposed a price cap on coronary stents.
The Shanghai-based company said its Firehawk Rapamycin target eluting coronary stent system was successfully used in a procedure in Mumbai earlier in the month, marking the 1st time the device saw use in the country.
The procedure was performed at H. J. Doshi Ghatkopar Hindu Sabha Hospital in Mumbai, by Dr. Anil Potdar, according to a press release. The company touted the Indian market as having the 3rd largest amount of PCI cases in the world, and promised future expansi...
Source: Mass Device - February 28, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiac Implants Cardiovascular Stents MicroPort Scientific Source Type: news
Cath Lab Recap: Fully Percutaneous EVAR; Aneurysms Within BVS
(MedPage Today) -- Interventional cardiology news to note (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 9, 2017 Category: Cardiology Source Type: news
Lombard wins Japanese clearance for IntelliFlex LP delivery device for Aorfix stent graft
Lombard Medical Technologies (NSDQ:EVAR) said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its Intelliflex low profile delivery system for the Aorfix endovascular stent graft.
The Oxfordshire, England-based company said it will initiate a commercial launch of the device in Japan once it receives reimbursement approval, expected some time next month. Currently, Medico’s Hirata has exclusive distribution rights to the Aorfix.
“We have enjoyed great success already with Aorfix in Japan and built our market share to approximately 8% over the last two years. Now with the appro...
Source: Mass Device - January 5, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Regulatory/Compliance Vascular Lombard Medical Technologies Source Type: news
China ’ s Microport puts $15m into Lombard Medical
Lombard Medical Technologies (NSDQ:EVAR) said today that China’s MicroPort Orthopedics invested $15 million as part of a partnership deal between the 2 companies.
Through the partnership, Lombard will seek to accelerate commercialization of its Arofix and Altura stent grafts for treating abdominal aortic aneurysms. Microport will gain exclusive marketing rights for both products in China and Brazil, as well as a license to manufacture the products for the Chinese market.
As part of the deal, Microport and Lombard said they entered a component supply manufacturing deal, with Microport manufacturing components for t...
Source: Mass Device - December 19, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Mergers & Acquisitions Stent Grafts Vascular Lombard Medical Technologies MicroPort Scientific Source Type: news
Essential Medical Inc. Announces the Successful Initiation of the U.S. MANTA Vascular Closure Device Trial With the First Patients Enrolled in TAVR and EVAR Cases
MALVERN, Pennsylvania, December 12, 2016 -- (Healthcare Sales & Marketing Network) -- Essential Medical, Inc., a privately held medical device company addressing the rapidly growing $600M large bore vascular closure market, announced today the start of th... Devices, Interventional, Cardiology Essential Medical, MANTA, Vascular Closure, TAVR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2016 Category: Pharmaceuticals Source Type: news
Medtronic wins expanded CE Mark indication for Endurant II stent graft
Medtronic (NYSE:MDT) said today that it won an expanded CE Mark indication in the European Union for its Endurant II/IIs stent graft for treating abdominal aortic aneurysms.
The expanded indication covers a new endovascular implantation approach using a parallel graft chimney approach called ChEVAR, which allows the device to be used to treat aneurysms with an aortic neck length of 2mm or more. Aortic neck length is the distance from the renal arteries to the aneurysm.
The ChEVAR approach, which uses balloon-expandable covered stents in the renal arteries and a stent graft in the aorta, is designed to increase the infraren...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Regulatory/Compliance Stent Grafts Medtronic Source Type: news
Veith 2016 Roundup: Stent grafts take center stage
Medtronic touts Endurant stent graft data from Engage study
Medtronic (NYSE:MDT) touted data from a series of sub-group analyses from the 10-year 1,200-patient Engage study of its Endurant II and Endurant IIs stent grafts for treating abdominal aortic aneurysms last week at the annual Veith Symposium on vascular disease.
First-time results from a review of the occurrence of endoleaks at the aneurysm neck, presented by Dr. Hence Verhagen of Erasmus University Medical Center in Rotterdam, Holland, showed a 97.8% rate of freedom from Type Ia endoleaks at 1 year. The rate was 97.3% at 2, 96.7% at 3 years and 96% at 4 years....
Source: Mass Device - November 21, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Stent Grafts Stents Vascular Biotronik Endologix Inc. Medtronic Veith Symposium 2016 W.L. Gore & Associates Source Type: news
Endovascular Repair May Be Effective for Ascending Aortic Dissection Endovascular Repair May Be Effective for Ascending Aortic Dissection
Endovascular repair appears to be effective for ascending aortic dissection in patients ineligible for open repair, researchers from China report.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 1, 2016 Category: Radiology Tags: News Source Type: news
Follow-Up Essential After Endovascular AAA Repair Follow-Up Essential After Endovascular AAA Repair
Compared to an open approach, endovascular repair (EVAR) of abdominal aortic aneurysm (AAA) offers early survival benefit but shows inferior late survival, according to UK researchers.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 31, 2016 Category: Radiology Tags: Neurology & Neurosurgery News Source Type: news
Gore wins Medicare add-on status for Excluder stent graft
W.L. Gore & Assoc. said today that it won new technology status from the U.S. Centers for Medicare & Medicaid Services for its Gore Excluder iliac branch endoprosthesis.
Set to go into effect Oct. 1, the change will allow facilities that use the device, in conjunction with Gore’s Excluder AAA device for endovascular aneurysm repair, to be eligible for a new tech add-on payment of up to $5,250 per case. The payment will come in addition to the applicable base payment for the Medicare Severity Diagnosis-related group.
“Prior to the IBE, there were limited options for maintaining blood flow to the inter...
Source: Mass Device - September 27, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Stent Grafts Vascular Reimbursement W.L. Gore & Associates Source Type: news
Gore launches DrySeal Flex introducer sheath
W.L. Gore & Associates said today it is launching its DrySeal Flex introducer sheath designed for use with its Gore Excluder iliac branch endoprosthesis device, which is used for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.
The newly-launched device is designed with improved flexibility, kink resistance and a hydrophilic coating to allow for access in challenging anatomies and branch vessels during endovascular repair procedures.
“Nearly a third of patients being considered for EVAR have an aneurysm that extends to the iliac artery. The IBE is a trusted solution in such cas...
Source: Mass Device - August 30, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters Vascular W.L. Gore & Associates Source Type: news
Endologix touts 1st Ovation Alto stent graft implantations
Endologix (NSDQ:ELGX) last week announced that its Ovation Alto abdominal stent graft system has been used in its 1st 2 procedures to treat abdominal aortic anneurysms.
The procedures were performed at New Zealand’s Auckland City Hospital by Dr. Andrew Holden and Dr. Andrew Hill, the Irvine, Calif.-based company said.
“The 1st patients treated with the Ovation Alto system is a significant milestone for our new product strategy. It further enhances our leadership position in the development of unique sealing technologies for the treatment of AAA and broadens our product portfolio to address a wide range of a...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Surgical Vascular Endologix Inc. Source Type: news
Lombard Medical exits U.S. market, shares jump
Lombard Medical Technologies (NSDQ:EVAR) said yesterday that it’s bailing out of the U.S. market after an FDA decision requiring a 50-patient clinical study of its Intelliflex low-profile delivery system for the Aorfix stent graft.
Lombard said it eliminated its U.S. sales force and moved most of its commercial operations to its U.K. facility, significantly reducing its cash burn.
Irvine, Calif.-based Lombard said it plans to focus exclusively on the European Union, Japan and other “key” international markets. The company in June won CE Mark approval in the European Union for the IntelliFlex device....
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic MassDevice Earnings Roundup Stent Grafts Wall Street Beat Lombard Medical Technologies Source Type: news
